Hong Kong, Aug 11, 2009 (ABN Newswire) - Lee’s Pharmaceutical Holdings Limited (“Lee’s Pharmaceutical” or the “Group”, Stock Code: HKG:8221) is an integrated, research-driven and market-oriented pharmaceuticals group in China, signed a subscription agreement with Vivo Ventures Fund Cayman VI. L. P. (Vivo Ventures Fund), allowing the Group to enter into a strategic partnership with a financial investor experienced in biotechnology and pharmaceutical business.
